Trials / Completed
CompletedNCT01443013
Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient
Predictive Value Analysis of Messenger Ribonucleic Acid (mRNA) Urinary Expression of Foxp3 and Vimentin on Graft Outcome in Renal Transplant Recipient: National Prospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 266 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study is designed to analyse the urinary mRNA expression of Foxp3 and Vimentin, two genes involved in tolerance and early graft dysfunction in 500 renal transplant recipients from 17 renal transplant site in France and to determine the predictive value of these gene expression on the one year graft outcome including graft function, one-year graft histological analysis and incidence of acute rejection.
Detailed description
This observational study is designed to analyse the urinary mRNA expression of Foxp3 and Vimentin, two genes involved in tolerance and early graft dysfunction in 500 renal transplant recipients from 17 renal transplant site in France and to determine the predictive value of these gene expression on the one year graft outcome including graft function,
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Renal Transplant | urinary sample at month 3, 6 and 12 |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2014-12-01
- Completion
- 2015-01-01
- First posted
- 2011-09-29
- Last updated
- 2015-10-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01443013. Inclusion in this directory is not an endorsement.